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Background: In hypersensitivity pneumonitis (HP), survival can be predicted on the basis of the
severity of fibrosis in surgical lung biopsy, but few data are available on the influence of clin-
ical, functional, tomographic and histologic findings on prognosis.
Objectives: To describe the impact on survival of clinical data, histological patterns, and HRCT
findings in subacute/chronic HP.
Methods: A retrospective analysis of 103 patients diagnosed with HP submitted to surgical lung
biopsy. Chronic HP was characterized by HRCT findings indicative of fibrosis (nZ 76).
Results: The most relevant exposures were to molds and birds. Lung biopsies revealed typical
HP with granulomas in 46 patients, bronchiolocentric interstitial pneumonia in 27, and non-
specific interstitial pneumonia (NSIP) in 16. By univariate analysis, several findings were
predictors of mortality: older age, male sex, velcro crackles, higher FEV1/FVC ratio, lower
oxygen saturation during exercise, and absence of mosaic pattern/air trapping and presence
of fibrosis on HRCT. By multivariate analysis, remained significant: age (pZ 0.007), oxygen
saturation during exercise (p Z 0.003), and mosaic pattern/air trapping on HRCT
(pZ 0.004). Patients with NSIP had a greater survival than did those with typical histology
and those with bronchiolocentric pneumonia (pZ 0.033).de Toledo, 1800, Bloco F, 3 andar, CEP: 04039-901, Sa˜o Paulo, SP, Brazil. Tel.: þ55 11 5549 1830;
com.br (M.S. Lima).
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Hypersensitivity pneumonitis and survival 509Conclusions: A wide range of histological features are found in HP. Typical findings are seen in
45% of cases. Other common patterns are NSIP and centriacinar lesions. Survival is better in
patients with NSIP and worse in those with older age, desaturation during exercise, and
absence of mosaic pattern/air trapping on HRCT.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Hypersensitivity pneumonitis (HP) is a pulmonary disease
caused by inhalation of any of various antigens that trigger
a diffuse inflammatory response in the small airways and
pulmonary parenchyma. The classic histological HP triad
includes the following:1,2 chronic interstitial pneumonia
with peribronchiolar accentuation; bronchiolitis; and non-
caseating granulomas. Granulomas, however, are not
present in all cases. In acute HP, granulomas are seen in 70%
of cases.3 In the subacute and chronic forms of HP, granu-
lomas are even less common.4,5
Various histopathological patterns included in the clas-
sification of idiopathic interstitial pneumonias,5e7 can
result from exposure to organic antigens. In recent years,
a new form of idiopathic interstitial pneumonia, with
bronchiolocentric distribution of inflammation or fibrosis, in
absence of granulomas and giant cells has been descri-
bed.8e11 HP can be a common cause of this form of inter-
stitial pneumonia.7 Due to peripheral deposition of
antigens, HP can also result in a spectrum of isolated small
airway diseases, including constrictive bronchiolitis.12,13
The influence of the most common histological patterns
associated with HP on survival is unknown.
In HP, the prognosis can be predicted on the basis of the
severity of fibrosis observed in open lung biopsy.14,15 However,
in many cases, the diagnosis can made by non-invasive
methods,16 so clinical prognostic findings are of interest. In
a recent study, univariate analysis demonstrated that evidence
of fibrosis on high-resolution computed tomography (HRCT),
more severe lung function abnormalities, and the presence of
crackles on auscultation were predictive of reduced survival.17
In the present study, we describe the histopathological
patterns in subacute and chronic HP, in a large sample of
patients submitted to surgical lung biopsies. In addition, we
sought to determine whether clinical, physiological,
tomographic data and individual major histological patterns
correlate with survival.
Methods
Selection of cases
The present study refers to an observational cohort of 103
adult patients with HP. The medical records of 1240
patients with interstitial lung diseases, evaluated between
January of 1995 and December of 2006 at two facilities in
the city of Sa˜o Paulo, Brazil, were reviewed. Of those, 200
received a final diagnosis of HP. From this sample, 97
patients were excluded for the following reasons: 53 did
not undergo lung biopsy (due to advanced age, clinical
improvement with avoidance of further antigen exposure,
very mild disease or high surgical risk); 17 were diagnosedthrough transbronchial biopsy; 10 presented concomitant
gastroesophageal reflux; five had end-stage lung disease;
six presented accompanying conditions, such as pneumo-
coniosis and collagen vascular diseases; three had acute
HP; two presented granulomatous pneumonitis as an
adverse drug effect; and one was <18 years old. Therefore,
the final sample comprised 103 patients.
Clinical analysis and HRCT
A standardized protocol was applied to all patients. Data
related to relevant exposure were recorded. Exposure to
molds was characterized by reporting of extensive visible
mold at home or in the workplace. Collagen vascular
diseases, exposure to inorganic dusts, or other causes of
lung fibrosis were carefully excluded by clinical and labo-
ratorial data.
Pulmonary function tests were conducted according to
the American Thoracic Society guidelines.18 The normal
values were those previously derived for the Brazilian
population.19 Peripheral oxygen saturation was evaluated
at rest and after a self-paced step test exercise.20,21
The HRCT scans were done in all patients (nZ 103) at
the time of diagnosis. Of those, 85 were reviewed by an
expert radiologist (DJ) for the presence or absence of
findings associate with subacute HP and findings indicative
of fibrosis. In the remaining cases (nZ 18), the initial
report, done in a systematic way by pulmonologists, was
included in the final analyses. The findings on HRCT asso-
ciate with subacute HP are ground-glass opacities, mosaic
pattern/air trapping, and centrilobular nodules.22e24 On
HRCT scans, profuse, poorly-defined centrilobular nodules
with ground-glass attenuation e or the combination of at
least two or more the following findings: ground-glass
opacities, poorly-defined centrilobular nodules, and
a mosaic pattern and/or air trapping on expiratory HRCT e
were considered highly suggestive of HP in non-smokers
with relevant exposure. Chronic HP was characterized by
HRCT findings indicative of fibrosis (reticular pattern,
traction bronchiectasis or honeycombing), superimposed or
not on findings associated with subacute HP.25e27 Findings
not compatible with HP (pleural effusion, lymphadenop-
athy, large nodules or masses) should be absent.
Histological findings
The histological examinations were reviewed by two
pulmonary pathologists (ENAMC and RGF) by consensus.
Typical HP was defined as patchy, chronic interstitial
pneumonia with peribronchiolar accentuation and non-
necrotizing granulomas or giant cells.1,2 The histological
patterns associated with organizing pneumonia, non-
specific interstitial pneumonia (NSIP), and usual interstitial
510 M.S. Lima et al.pneumonia (UIP) were classified according to the American
Thoracic Society/European Respiratory Society
consensus.28 In the absence of granulomas or giant cells,
extensive areas of organizing pneumonia combined with
fibrosis were seen.29 Constrictive bronchiolitis was charac-
terized as submucosal and peribronchiolar fibrosis with
surrounding parenchyma free of involvement.30 The bron-
chiolocentric interstitial pneumonia (BIP) pattern was
defined according with the combination of criteria by
Yousem and Dacic9 and Churg et al.10 as centrilobular/
bronchiolocentric chronic inflammatory infiltrate associ-
ated or not with fibrosis. Sparse foci of fibromyxoid tissue
and honeycombing could also be found. In many instances,
there was prominent bronchiolar metaplasia overlying the
fibrotic alveolar walls.
Case definition
Subacute HP was characterized as symptom duration of
greater than 3 months and no fibrosis on HRCT scans.
Chronic HP was characterized by HRCT findings indicative of
fibrosis, irrespective duration of symptoms. The diagnosis
of typical HP was based on the classic histological triad.
Diagnosis of non-typical HP was done by: (1) relevant
exposure preceding respiratory symptoms; (2) presence of
episodic or persistent respiratory symptoms; (3) at least
one of following HRCT findings consistent with HP-bilateral
ground-glass, poorly defined centrilobular nodules, areas
lobular air trapping or fibrotic changes considered to be
atypical for UIP, that is, without subpleural fibrotic
changes, lower zone predominance, and minimal to no
ground-glass infiltration; (4) consistent histopathological
findings as described above (organizing pneumonia, NSIP,
UIP, BIP or constrictive bronchiolitis); and (5) no other
identifiable cause for the lung disease. Precipitin tests and
bronchoalveolar lavage (BAL) were not available in the
majority of cases.
Treatment and survival
Patients were treated at discretion of assistant physicians if
the avoidance of presumed antigen was not attained, or
symptoms and respiratory function tests or blood gases
abnormalities remained significant. Corticosteroids isolated
or associated with cytotoxic agents were prescribed.
In major histopathological groups, spirometric values for
forced vital capacity (FVC) obtained prior to the lung biopsy
were compared to those obtained in the last visit (intervals
ranged from 4 to 96 months, median 23 months).
Survival was assessed through May of 2006. Deaths were
identified by follow-up contact or through telephone noti-
fication by relatives. Deaths were considered HP-related if
due to respiratory failure, pneumonia, or pulmonary
fibrosis. One patient was censored at the time of lung
transplantation.
Statistical analysis
All data analyses were performed using the SPSS program,
version 13.0.31 Continuous data are expressed as
mean  SD, or as median and range. Continuous data withnormal distribution were compared using t-tests and
ANOVA. Continuous data with non-normal distribution
were compared using the KruskaleWallis test. The chi-
square test was used for comparisons of proportions.
Values for FVC measured before and after treatment were
compared by paired t -test. Survival time was calculated
from the day of the biopsy. Cox proportional hazards
regression was used to assess significant variables that
influenced mortality. Variables were chosen for inclusion
in the model if statistically significant by univariate
analyses. The final Cox regression model was evaluated in
the forward selected stepwise multivariate Cox regression
analysis. Cumulative survival probabilities for histopath-
ologic groups and desaturation status groups were esti-
mated using the KaplaneMeier method and log-rank tests.
Two-sided p values < 0.05 were considered statistically
significant.
The study design was approved by the ethics committees
of the hospitals involved.
Results
Clinical findings
The study sample comprised 103 cases (64 females/39
males), 27 with subacute HP and 76 with chronic HP.
Exposure to molds was reported by 36 patients, to birds by
28, and to both by 25. Exposure to isocyanates only was
reported by seven patients. In the remaining six cases there
was a combined exposure of isocyanates with molds in four
and with birds in two. Only one patient reported no rele-
vant exposure, but presented typical histological findings at
lung biopsy. Comparison among the patients by type of
exposure revealed no differences in clinical, functional,
imaging, or histological findings.
The mean age was 56  13 years (range, 18e78 years).
Thirteen patients (13%) were smokers at the onset of
symptoms. The median duration of symptoms was
18 months (range, 0e120 months). The main clinical
features were dyspnea (in 88, 85%) and cough (in 80, 78%).
Weight loss was reported by 30 patients (29%). Velcro
crackles were heard in 63 (61%) and ‘squawks’ in 10 (10%).
Clubbing was observed in 27 (26%). Ninety-nine patients
performed acceptable spirometry tests. Mean FVC was
69  20% of predicted and FEV1/FVC ratio was 85  7%.
Eighty-two patients completed a step test, with at least
3 min of duration. In these cases, the SpO2 dropped from
95  3% at rest to 88  7% at the end of exercise.
HRCT findings
The most frequent HRCT patterns were ground-glass opac-
ities (in 82, 80%) and findings indicative of fibrosis (in 76,
74%). Centrilobular nodules were seen in 34 (33%), mosaic
pattern/air trapping in 44 (43%), and cysts in 13 (13%). In 16
(16%), we observed diffuse centrilobular nodules, which
was the only finding in three cases. A highly suggestive
HRCT pattern was seen in 20 (74%) of the subacute HP
patients and in 40 (53%) of those with chronic HP
(c2Z 3.77, pZ 0.052). Highly suggestive findings on HRCT
scans were seen in similar proportions in the 28 patients
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presenting other histological patterns (c2Z 2.86,
pZ 0.091).
Histological findings
In 46 patients, the histological examination of the biopsies
showed classical or typical findings, with granulomas or giant
cells and chronic interstitial pneumonia with peribronchiolar
accentuation. Other common histological patterns included
BIP (nZ 27) and NSIP (nZ 16, cellular pattern in four and
fibrotic pattern in 12). Baseline characteristics according to
histopathologic subgroup are shown in Table 1. Among the
patients with NSIP, the mean age was lower and the mean
duration of symptoms was shorter than among the patients
with typical HP and those with BIP. Velcro crackles at
auscultation and honeycombing on HRCT scans were more
common among patients with BIP than among those with
typical HP. Patients with typical HP presented lower FEV1/
FVC ratios and more centrilobular nodules on HRCT scans, as
well as less frequently presenting honeycombing (Table 1).
In five patients, a pattern of constrictive bronchiolitis
was seen, without associated interstitial findings. An
organizing pneumonia pattern was seen in five patients,
three of whom presented associated fibrosis.Table 1 Baseline characteristics according to histopathologic s
Characteristic Typical HP
Age, year (mean  SD) 58  11
Sex, male/female 16/30
Smokers, n (%) 6 (13)
Duration of symptoms, in months, median (range) 17 (0e120
Weight loss, n (%) 10 (22)
Clubbing, n (%) 9 (20)
Velcro crackles, n (%) 24 (52)
Pulmonary function
FVC, % predicted 72.7  20.
FEV1/FVC ratio, % 81.7  7,1
Oxygen saturation, %
At rest (mean  SD) 95.2  1.8
During exercise
(mean  SD)
87.5  6.8
HRCT findings
Centrilobular nodules, n (%) 31 (67.4)
Ground-glass opacities, n (%) 33 (71.7)
Mosaic pattern/air
trapping, n (%)
21 (45.7)
Honeycombing, n (%) 16 (45.7)
Findings of fibrosis, n (%) 30 (65)
Treatment
Corticosteroids, n (%) 41 (89)
Cytotoxic agents, n (%) 18 (39)
Definition of abbreviations: HPZ hypersensitivity pneumonitis; NSIP
interstitial pneumonia; HRCTZ high-resolution computed tomograp
capacity.
* nZ 46 except pulmonary function (nZ 44) and honeycombing (n
y nZ 16 except honeycombing (nZ 14).
z nZ 27 except pulmonary function (nZ 25) and honeycombing (n
x p value associated with the overall comparison across histopathol
and c2 test for categorical variables. p significant at < 0.05.There were four patients who had typical UIP findings at
biopsy, although areas of bronchiolocentric distribution
were also apparent in two. The HRCT findings were not
suggestive of UIP in any of these cases.
Survival
The median post-biopsy follow-up period was 36 months. A
total of 5 years after diagnosis, 27% of the patients have
died. There were 17 deaths secondary to HP during the
study period. By Cox univariate analysis, several findings
were significant predictors of mortality by HP: older age,
male sex, velcro crackles, higher FEV1/FVC ratio, lower
oxygen saturation during exercise, use of cytotoxic agents
on treatment, and regarding the findings on HRCT, absence
of mosaic pattern/air trapping, presence of honeycombing,
and presence of fibrosis (Table 2). By multivariate analysis,
mortality was associated with older age, lower oxygen
saturation during exercise, and absence of mosaic pattern/
air trapping on HRCT (Table 3).
Considering these three prognostic factors (older age,
lower oxygen saturation during exercise, and absence of
mosaic pattern/air trapping on HRCT), and changing oxygen
saturation according a cutoff point of 88%, the oxygen
saturation was selected as the most important predictor ofubgroup in patients with hypersensitivity pneumonitis.
(nZ 46)* NSIP (nZ 16)y BIP (nZ 27)z p valuex
48.4  15.5 57.1  12 0.025
5/11 12/15 0.617
2 (13) 5 (19) 0.787
) 9.5 (2e76) 38 (0e87) 0.023
9 (56) 9 (33) 0.037
3 (19) 9 (33) 0.36
10 (63) 23 (85) 0.018
5 58.5  16.7 69.3  19.9 0.055
87.2  5.2 88.3  6.8 <0.001
92.9  5,4 95.1  1.8 0.333
84.4  5.6 88.7  5.6 0.088
3 (18.8) 11 (40.7) 0.002
14 (87.5) 23 (85.2) 0.254
6 (37.5) 9 (33.3) 0.565
9 (64.3) 19 (79.2) 0.034
12 (75) 24 (89) 0.083
15 (94) 24 (89) 0.852
9 (56) 9 (33) 0.323
Z non-specific interstitial pneumonia; BIPZ bronchiolocentric
hy; FEV1Z forced expiratory volume in 1 s; FVCZ forced vital
Z 35).
Z 24).
ogic subgroups using analysis of variance for continuous variables
Table 2 Results of univariate analysis of prognostic
factors in patients with hypersensitivity pneumonitis.
Variables Hazard
ratio
95% CI p value
Older age 1.05 1.00e1.09 0.049
Male sex 3.49 1.32e9.27 0.012
Duration of symptoms 1.01 0.99e1.02 0.562
Clubbing 1.02 0.33e3.13 0.978
Velcro crackles 7.15 1.63e31.45 0.009
Pulmonary function
FVC, % predicted 0.98 0.96e1.01 0.180
FEV1/FVC ratio, % 1.08 1.01e1.15 0.020
Higher oxygen
saturation, %
At rest 0.99 0.87e1.13 0.889
During exercise 0.92 0.86e0.99 0.025
HRCT findings
Centrilobular nodules 1.47 0.56e3.86 0.437
Ground-glass opacities 1.66 0.58e4.71 0.343
Mosaic pattern/air trapping 0.26 0.07e0.90 0.034
Findings of fibrosis 8.14 1.08e61.61 0.042
Honeycombing 5.73 1.26e26.05 0.024
Typical HP* 1.75 0.64e4.76 0.274
Use of cytotoxic
agents on treatment
3.58 1.26e10.16 0.017
Definition of abbreviations: CIZ confidence interval; FVCZ
forced vital capacity; FEV1Z forced expiratory volume in
1 s; HRCTZ High-resolution computed tomography; HPZ
hypersensitivity pneumonitis.
* Typical HP was defined as typical histological findings,
including granulomas or giant cells.
Figure 1 KaplaneMeier survival curves for patients with
hypersensitivity pneumonitis, stratified by desaturation
(oxygen saturation of 88% or less) during a step test. Patients
without desaturation 88% (nZ 41, dashed line) had signifi-
cantly better survival than did those with desaturation 88%
(nZ 41, solid line), (log-rankZ 13.53, p < 0.001).
512 M.S. Lima et al.mortality, by a forward stepwise analysis (hazard ratio
[HR]Z 16.55, 95% confidence interval [CI]Z 2.17e126.15,
pZ 0.007). In patients with oxygen saturation of 88% or
less at the end of exercise (desaturation), 43% had died
after 5 years, compared to 4% of those with oxygen satu-
ration above of 88% (log-rankZ 13.53, p < 0.001)
(Figure 1). Desaturation on step test remained as the main
predictor of mortality after adjusting for age, sex, velcro
crackles, findings of fibrosis on HRCT, and FEV1/FVC ratio
(HRZ 14.96, 95% CIZ 1.96e114.00, pZ 0.009).Table 3 Results of multivariate analysis of prognostic
factors in patients with hypersensitivity pneumonitis.
Characteristic Hazard
ratio
95% CI p value
Older age 1.10 1.03e1.18 0.007
Higher oxygen
saturation, %
During exercise 0.88 0.80e0.96 0.003
HRCT findings
Presence of mosaic
pattern/air trapping
0.05 0.01e0.39 0.004
Definition of abbreviations: CIZ confidence interval;
HRCTZ high-resolution computed tomography.Outcomes and survival in major histologic groups
Antigen avoidance and abatement procedures were rec-
ommended in all cases. In major histologic groups (nZ 89),
a similar proportion of cases were treated with cortico-
steroids and cytotoxic agents (Table 1). Antigen avoidance
was sufficient for disease control in six patients of these
groups. Considering the three major histological patterns
with functional follow-up (nZ 70), the changes in FVC
were: 0.044  0.48 L in typical HP (nZ 38);
0.262  0.50 L in NSIP (nZ 13) and 0.157  0.41 L in BIP
(nZ 19), (FZ 3.23, pZ 0.046). A post hoc analysis
showed that the NSIP group presented a significantly
greater increase in FVC in comparison to BIP group
(pZ 0.04).
Mortality was similar between those with typical HP and
those with BIP (pZ 0.66). However, survival was greater in
patients with NSIP (nZ 16) than in those with typical HP
and BIP groups (nZ 73, log-rankZ 4.56, pZ 0.033;
Figure 2). None of the patients with NSIP died during the
study period, compared with 11 with typical HP and five
with BIP (pZ 0.039). When only patients presenting
evidence of fibrosis on HRCT scans were compared, survival
was still greater in the NSIP group (nZ 12) than in the
typical HP/BIP group (nZ 54) (log-rankZ 4.83,
pZ 0.028). When only patients treated with cytotoxic
agents were compared, those with NSIP had a better
survival (log-rankZ 5.76, pZ 0.016). When significant
predictors of mortality by univariate analysis (see Table 2)
were added with major histologic patterns in a multivariate
analysis, the model did not converge by the small numbers
of cases with NSIP and by the lack of deaths in this group.
Discussion
In the present study, we found that patients with subacute
and chronic HP display a wide range of histological
features. Less than half of patients disclosed classical
findings of HP in surgical lung biopsy. Several findings were
Figure 2 KaplaneMeier survival curves for patients with non-
specific interstitial pneumonia (NSIP: nZ 16, dotted line),
typical hypersensitivity pneumonitis (Typical HP: nZ 46,
dashed line), or bronchiolocentric interstitial pneumonia (BIP:
nZ 27, solid line), grouped by histologic classification. There
was no significant difference between those with typical HP
and those with BIP (log-rankZ 0.19, pZ 0.66). Patients with
NSIP had significantly better survival than did those with
typical HP and those with BIP (log-rankZ 4.56, pZ 0.033).
Hypersensitivity pneumonitis and survival 513predictive of mortality in HP, including histologic pattern
and some findings on HRCT, but the best predictor seemed
to be oxygen saturation during exercise.
Histological findings
In our sample, 45% of the cases presented typical histo-
logical findings, including granulomas or giant cells. In HP,
the degree of bronchiolar involvement tends to be
proportional to the severity of fibrosis seen in the lung
parenchyma,12 although isolated constrictive bronchiolitis
can be seen.12,13 In our sample, five patients presented
a pattern consistent with constrictive bronchiolitis. In four
of these cases, air trapping was the only HRCT finding.
Bronchiolitis with poorly-defined granulomas or isolated
giant cells on lung biopsy in patients with relevant exposure
has been described.13 Some authors have reported orga-
nizing pneumonia to be a possible HP pattern.5,32 In three
of our cases, a mixed pattern of fibrosis and extensive
organizing pneumonia was found.
A distinctive picture of bronchiolocentric injury has been
referred to by a variety of terms, including centrilobular
fibrosis, idiopathic BIP, airway-centered interstitial fibrosis,
and peribronchiolar metaplasia.8e11 This is distinctly
different from the peripheral pattern of fibrosis observed in
UIP. In our patients, BIP without granulomas was seen in 27
cases: inflammation was present in all and peribronchiolar
fibrosis in 25 (93%); sparse foci of intraluminal polyps in 21
(78%); and honeycombing in 12 (46%).
The NSIP pattern is now recognized as a possible
expression of HP. This pattern was seen in 16 of our cases.
Four cases were defined as UIP based on the biopsy,
although areas of bronchiolocentric distribution were
apparent in two of those cases. A typical UIP pattern can
represent idiopathic pulmonary fibrosis with coincidental
exposure14 or a non-representative biopsy. In our four cases
presenting UIP histological pattern, the HRCT findings wereatypical for UIP in all. In cases with granulomas or giant cell
are associated with any other pattern of interstitial pneu-
monia, a diagnosis of HP should be considered.
Patients with typical HP had greater frequency of cen-
trilobular nodules in comparison to NSIP and BIP patterns. In
the present study, the mean age was lower and the mean
symptom duration was shorter in the patients with NSIP
than in those with typical HP or BIP. Patients with BIP had
greater frequency of velcro crackles at lung auscultation
and honeycombing at HRCT, suggesting a more advanced
disease in comparison to cases with typical HP and NSIP. We
suggest that BIP reflects an advanced stage of HP, with
fibrosis around the airways after an inflammatory phase,
with disappearance of granulomas or giant cells. Our study
shows that survival among HP patients varies depending on
the histological pattern. No patient with NSIP died during
the follow-up. Patients presenting NSIP pattern having the
greatest survival.
Future attempts to classify the fibrosing interstitial lung
diseases should take into account clinical and radiological
manifestations, and new methods, like gene expression
profile of disease, rather than relying simply on subtle
histological differences as the basis for the definition of
separate disease entities.33,34
Survival
Survival has been evaluated in a few studies involving
patients with subacute or chronic HP.14,15 In our study, total
mortality in 5 years was 27%, very similar to the 29% found
in a study conducted in Mexico.14 In both studies, contin-
uous low-grade domestic exposure to antigen was the main
cause of HP. However, in our study, in only 17% of cases the
death was attributed to HP.
The presence of fibrosis seen in lung biopsy is known to
be the major determinant of survival in HP.5,7,14,15 Sahin
et al. concluded that HRCT findings indicative of fibrosis
were not associated with a worse survival, but only 26
patients were included in their study.27 A recent study
found that the presence and extent of fibrosis in HP are
associated with reduced survival.17 In our sample, the
presence of fibrosis at HRCT had influence on survival.
In our study, several variables correlated with mortality.
In agreement with other studies,17,35 patients with higher
FEV1/FVC ratio had a higher mortality. Increased FEV1/FVC
ratio is due to increased lung elastic recoil and/or decrease
in resistance of airways. Both are consequence of lung
fibrosis.
The absence of mosaic attenuation or air trapping on
HRCT was a significant predictor of mortality. These findings
on HRCT reflect small airflow obstruction due to bronchio-
litis in HP. Patients with mosaic pattern had findings
indicative of fibrosis on HRCT in a smaller proportion
(pZ 0.013). It can be postulated that as the disease
becomes more severe, the findings indicative of air trap-
ping tend to disappear. In the present study, clubbing did
not relate to survival. Similar findings were seen in other
recent study.17
In patients with UIP, desaturation during a 6 min walking
test or at the end of a step test is strongly predictive of
mortality.21,36 During exercise, gas exchange in IPF is
influenced by ventilation-perfusion mismatching, oxygen
514 M.S. Lima et al.diffusion and increased pulmonary vascular resistance.37,38
In our study, oxygen desaturation during a step test was the
better predictor of survival in patients with subacute and
chronic HP. Patients with desaturation of 88% or less had
a hazard of 15 fold of dying due to HP after considering
other variables related to survival, but confidence interval
was wide.
Limitations
There are several limitations to our study. The diagnosis of
HP was largely based on clinical and radiologic findings.
Relevant exposure was characterized by history. Patients
with several histological patterns, including organizing
pneumonia, UIP, and NSIP, without granulomas or giant
cells, could have a coincident exposure. Serologic data
were not available for confirmation of exposure. In patients
with interstitial fibrosing lung disease, an increase in
lymphocytes in BAL, in the presence of exposure and
suggestive data on HRCT could obviate surgical lung biopsy,
but BAL was available in a small number of cases. We do
believe that bronchiolocentric interstitial pneumonia
should be incorporated in the classification of interstitial
pneumonias, but at present time, different criteria for this
diagnosis have been proposed by different authors.8e10
Finally, the impact of treatment on course of chronic HP
must be defined by randomized clinical trials. Nevertheless,
the effect of corticosteroids and cytotoxic agents seems to
be small.
Conclusions
In conclusion, subacute and chronic HP can exhibit a large
variety of histologic patterns. Typical findings are found in
less than half of cases. Others common patterns include
NSIP, and a bronchiolocentric interstitial pneumonia.
Patients with NSIP are younger, have a shorter duration of
symptoms, and greater survival. In contrast, patients with
BIP have more advanced disease and a worse prognosis.
Several factors are related to mortality, including older
age, male sex, higher FEV1/FVC ratio, velcro crackles,
presence of fibrosis and absence of mosaic pattern on
HRCT, and lower oxygen saturation during exercise. Irre-
spective other data, the best predictor of mortality seems
to be a fall in oxygen saturation at exercise of 88% or less.
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